Back to Search Start Over

Coexpression of Fc? receptor IIIA and interleukin-2 receptor ? chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes

Authors :
Simona Zupo
Bice Perussia
Alessandra D'Amato
Livio Azzoni
Manlio Ferrarini
Rosanna Massara
Source :
Journal of Clinical Immunology. 13:228-236
Publication Year :
1993
Publisher :
Springer Science and Business Media LLC, 1993.

Abstract

In this study we identify and characterize a subset of human peripheral blood T cells, present in all individuals, that has features previously described for T cells either separately or in special circumstances. These cells are found in purified suspensions of resting peripheral blood lymphocytes within the CD8+ T lymphocytes, express alpha beta T cell receptor (TCR), and can be identified and isolated because of high-density expression of surface CD11b (TCR alpha beta +/CD3+/CD8+/CD11b+ cells). They coexpress constitutively the IL-2 receptor beta chain, Fc gamma RIIIA, and CD56. Although they do not mediate spontaneous cytotoxicity, CD3+/CD8+/CD11b+ cells have cytotoxic potential, demonstrated in redirected cytotoxicity assays with P815 target cells in the presence of anti-Fc gamma RIII (CD16) or anti-CD3 monoclonal antibodies. Stimulation of CD3+/CD8+/CD11b+ cells with rIL-2 induces proliferation, cytotoxicity against NK-sensitive and NK-resistant target cells, and expression of surface activation antigens, including IL-2 receptor alpha chain (CD25). CD3+/CD8+/CD16+/CD56+ cell clones with cytotoxic functions including those mediated by engagement of surface CD16 were obtained by limiting-dilution cloning of purified CD3+/CD8+/CD11b+ cells in the presence of rIL-2 and autologous feeder cells. Our data support the hypothesis that the CD3+/CD8+/CD11b+/CD16+ cells represent a discrete peripheral blood lymphocyte subset that could be the physiological counterpart of that expanded in several pathological conditions and in large granular lymphocyte lymphocytosis.

Details

ISSN :
15732592 and 02719142
Volume :
13
Database :
OpenAIRE
Journal :
Journal of Clinical Immunology
Accession number :
edsair.doi.dedup.....4eaabb8ffb1d4eead91990fe17e496b7
Full Text :
https://doi.org/10.1007/bf00919976